Abstract
In this issue of Blood, Matte et al demonstrate that sickle cell disease (SCD) disrupts inflammation-resolution programs in a mouse model of SCD, giving evidence for an entirely new way to treat this disease.
MeSH terms
-
Anemia, Sickle Cell*
-
Docosahexaenoic Acids
-
Humans
-
Inflammation
-
Pain*
Substances
-
resolvin D1
-
Docosahexaenoic Acids